NCT05694728 2023-01-23A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineBeijing Health Guard Biotechnology, IncPhase 2 Completed780 enrolled
NCT05680454 2023-01-17A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV VaccineBeijing Health Guard Biotechnology, IncPhase 1 Completed160 enrolled
NCT05662020 2022-12-27A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in ChinaBeijing Health Guard Biotechnology, IncPhase 3 Active not recruiting2,750 enrolled